Cite

HARVARD Citation

    Morimoto, M. et al. (n.d.). Field practice study of half‐dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysis. Hepatology research. 45 (3), pp. 279-287. [Online]. 
  
Back to record